---
title: 04 Antiarrhythmics (Lesson 4 - Potassium Channel Blockers)
---
# 04 Antiarrhythmics (Lesson 4 - Potassium Channel Blockers)


<div class="video-wrapper">
  <video controls preload="metadata" playsinline>
    <source src="https://helly.s3.bitiful.net/å¿ƒè¡€ç®¡å­¦ç§‘/%E4%B8%93%E8%BE%91%2007%EF%BC%9A%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E8%AF%8A%E6%96%AD%E5%AE%9E%E6%88%98%20%28Arrhythmia%20Diagnosis%29/04%20Antiarrhythmics%20%28Lesson%204%20-%20Potassium%20Channel%20Blockers%29.mp4" type="video/mp4">
    <p>æ‚¨çš„æµè§ˆå™¨ä¸æ”¯æŒæ’­æ”¾ï¼Œè¯·å‡çº§ã€‚</p>
  </video>
</div>


::: tip âš¡ï¸ æ ¸å¿ƒè€ƒç‚¹ (30sé€Ÿè¯»)
*   **æ ¸å¿ƒè€ƒç‚¹**ï¼šç¬¬ä¸‰ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯ï¼ˆé’¾é€šé“é˜»æ»å‰‚ï¼‰é€šè¿‡é˜»æ–­é’¾é€šé“ï¼Œå»¶é•¿å¿ƒè‚Œç»†èƒåŠ¨ä½œç”µä½æ—¶ç¨‹å’Œæœ‰æ•ˆä¸åº”æœŸï¼Œä»è€Œæœ‰æ•ˆç»ˆæ­¢å’Œé¢„é˜²æŠ˜è¿”æ€§å¿ƒå¾‹å¤±å¸¸ï¼Œå°¤å…¶æ˜¯å¿ƒæˆ¿é¢¤åŠ¨ã€å¿ƒæˆ¿æ‰‘åŠ¨å’Œå®¤æ€§å¿ƒåŠ¨è¿‡é€Ÿã€‚
*   **ä¸´åºŠæ„ä¹‰**ï¼šæ­¤ç±»è¯ç‰©ï¼ˆå°¤å…¶æ˜¯èƒºç¢˜é…®ï¼‰ç–—æ•ˆæ˜¾è‘—ä½†å‰¯ä½œç”¨å¤æ‚ï¼Œéœ€è­¦æƒ•å°–ç«¯æ‰­è½¬å‹å®¤é€Ÿç­‰è‡´å‘½æ€§å¿ƒå¾‹å¤±å¸¸é£é™©ï¼Œç”¨è¯æœŸé—´å¿…é¡»ä¸¥å¯†ç›‘æµ‹QTé—´æœŸã€‚
:::

## ğŸ§  æ·±åº¦ç²¾è®²

*   **è¯ç‰©åˆ†ç±»ä¸ä½œç”¨æœºåˆ¶**ï¼šæœ¬è§†é¢‘èšç„¦äºVaughan Williamsåˆ†ç±»æ³•ä¸­çš„ç¬¬ä¸‰ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯â€”â€”é’¾é€šé“é˜»æ»å‰‚ã€‚å…¶æ ¸å¿ƒæœºåˆ¶æ˜¯é˜»æ–­å¿ƒè‚Œç»†èƒå¤æè¿‡ç¨‹ä¸­çš„é’¾ç¦»å­å¤–æµï¼Œä»è€Œå»¶é•¿åŠ¨ä½œç”µä½æ—¶ç¨‹å’Œæœ‰æ•ˆä¸åº”æœŸã€‚è¿™ä½¿å¾—æŠ˜è¿”ç¯è·¯ä¸­çš„å¼‚å¸¸ç”µå†²åŠ¨æ›´å®¹æ˜“è½å…¥å¿ƒè‚Œç»„ç»‡çš„â€œä¸åº”æœŸâ€è€Œè¢«é˜»æ–­ï¼Œå› æ­¤å¯¹æŠ˜è¿”æœºåˆ¶å¼•èµ·çš„å¿ƒå¾‹å¤±å¸¸ï¼ˆå¦‚æˆ¿é¢¤ã€æˆ¿æ‰‘ã€å®¤é€Ÿï¼‰ç‰¹åˆ«æœ‰æ•ˆã€‚
*   **ä¸»è¦è¯ç‰©æ¦‚è¿°**ï¼šç¾å›½ä¸´åºŠå¸¸ç”¨çš„å››ç§ä¸»è¦è¯ç‰©æ˜¯èƒºç¢˜é…®ã€å†³å¥ˆè¾¾éš†ã€ç´¢ä»–æ´›å°”å’Œå¤šéåˆ©ç‰¹ã€‚æ­¤å¤–ï¼Œä¼Šå¸ƒåˆ©ç‰¹ä½œä¸ºé™è„‰ç”¨è¯ï¼Œä¸“é—¨ç”¨äºæˆ¿é¢¤/æˆ¿æ‰‘çš„è¯ç‰©å¤å¾‹ï¼Œä½†ä½¿ç”¨è¾ƒå°‘ã€‚
*   **èƒºç¢˜é…®çš„â€œå¤šé¢æ€§â€ä¸å¤æ‚æ€§**ï¼š
    *   **ä½œç”¨æœºåˆ¶**ï¼šè™½ç„¶è¢«å½’ä¸ºç¬¬ä¸‰ç±»ï¼Œä½†èƒºç¢˜é…®å®é™…ä¸Šå…·æœ‰æ‰€æœ‰å››ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯çš„ç‰¹æ€§ï¼ˆå¤šé€šé“é˜»æ»ï¼‰ï¼Œè¿™è§£é‡Šäº†å…¶å¹¿è°±ç–—æ•ˆå’Œå¤æ‚çš„è¯ç†å­¦ã€‚
    *   **ä¸´åºŠåº”ç”¨**ï¼šç”¨äºæŠ‘åˆ¶å®¤æ€§å¿ƒåŠ¨è¿‡é€Ÿã€ç»´æŒæˆ¿é¢¤/æˆ¿æ‰‘æ‚£è€…çš„çª¦æ€§å¿ƒå¾‹ï¼Œä»¥åŠåœ¨Î²å—ä½“é˜»æ»å‰‚/é’™é€šé“é˜»æ»å‰‚ç¦å¿Œæ—¶æ§åˆ¶å¿ƒå®¤ç‡ã€‚å®ƒç”šè‡³å…·æœ‰ä¸€å®šçš„å¤å¾‹èƒ½åŠ›ã€‚
    *   **æ˜¾è‘—çš„å‰¯ä½œç”¨**ï¼šé•¿æœŸä½¿ç”¨å‰¯ä½œç”¨å¹¿æ³›ä¸”ä¸¥é‡ï¼ŒåŒ…æ‹¬**è‚ºçº¤ç»´åŒ–**ï¼ˆæœ€å±é™©ï¼Œéœ€åŸºçº¿èƒ¸ç‰‡å’Œè‚ºåŠŸèƒ½æ£€æŸ¥ï¼‰ã€ç”²çŠ¶è…ºåŠŸèƒ½å¼‚å¸¸ï¼ˆç”²å‡æˆ–ç”²äº¢ï¼Œå› å…¶å«å¤§é‡ç¢˜ï¼‰ã€è‚æ¯’æ€§ã€è§†è§‰åŠç¥ç»ç³»ç»Ÿç—‡çŠ¶ç­‰ã€‚é™è„‰æ¨æ³¨å¯å¼•èµ·ä½è¡€å‹ã€‚
    *   **ç‹¬ç‰¹çš„è¯ä»£åŠ¨åŠ›å­¦**ï¼šèµ·æ•ˆæ…¢ï¼Œåˆ†å¸ƒå®¹ç§¯å¤§ï¼ŒåŠè¡°æœŸæé•¿ï¼ˆæ•°å‘¨è‡³æ•°æœˆï¼‰ã€‚å› æ­¤ï¼Œèµ·å§‹æ²»ç–—éœ€è¦æ•°å‘¨çš„â€œè´Ÿè·å‰‚é‡â€ä»¥è¾¾åˆ°ç¨³æ€ï¼Œåœè¯åä½œç”¨ä¹Ÿä¼šæŒç»­å¾ˆä¹…ã€‚
    *   **ä¸´åºŠå®šä½**ï¼šå°½ç®¡ç–—æ•ˆå¼ºå¤§ï¼Œä½†ç”±äºå…¶æ˜¾è‘—çš„æ¯’æ€§ï¼Œåœ¨éœ€è¦é•¿æœŸæ²»ç–—æ—¶ï¼Œåº”è¢«è§†ä¸ºäºŒçº¿æˆ–ä¸‰çº¿é€‰æ‹©ã€‚
*   **å°–ç«¯æ‰­è½¬å‹å®¤é€Ÿ**ï¼š
    *   **å®šä¹‰ä¸å±é™©**ï¼šè¿™æ˜¯ä¸€ç§å‘ç”Ÿåœ¨QTé—´æœŸå»¶é•¿åŸºç¡€ä¸Šçš„ç‰¹æ®Šç±»å‹çš„å¤šå½¢æ€§å®¤æ€§å¿ƒåŠ¨è¿‡é€Ÿï¼Œå¿ƒç”µå›¾è¡¨ç°ä¸ºQRSæ³¢ç¾¤æŒ¯å¹…å’Œææ€§å›´ç»•ç­‰ç”µä½çº¿å‘¨æœŸæ€§æ‰­è½¬ã€‚å®ƒå¯è‡ªè¡Œç»ˆæ­¢ï¼Œä½†ææ˜“æ¶åŒ–ä¸ºå®¤é¢¤ï¼Œå¯¼è‡´çŒæ­»ã€‚
    *   **ä¸è¯ç‰©çš„å…³ç³»**ï¼šQTé—´æœŸå»¶é•¿æ˜¯ç¬¬ä¸‰ç±»è¯ç‰©çš„é¢„æœŸè¯ç†ä½œç”¨ï¼ˆå»¶é•¿ä¸åº”æœŸï¼‰ï¼Œä½†è¿‡åº¦å»¶é•¿ï¼ˆé€šå¸¸æŒ‡æ ¡æ­£åQTc > 500msï¼‰åˆ™æ˜¾è‘—å¢åŠ å‘ç”Ÿå°–ç«¯æ‰­è½¬å‹å®¤é€Ÿçš„é£é™©ã€‚å› æ­¤ï¼Œç”¨è¯æœŸé—´å¿…é¡»ä¸¥å¯†ç›‘æµ‹QTcã€‚
    *   **æ²»ç–—**ï¼šä¸€æ—¦å‘ç”Ÿï¼Œä¸€çº¿æ²»ç–—æ˜¯**é™è„‰æ³¨å°„é•å‰‚**ï¼Œæ— è®ºæ‚£è€…è¡€é•æ°´å¹³æ˜¯å¦æ­£å¸¸ã€‚
*   **å†³å¥ˆè¾¾éš†**ï¼šè§†é¢‘æåˆ°å†³å¥ˆè¾¾éš†æ˜¯èƒºç¢˜é…®çš„ç»“æ„ç±»ä¼¼ç‰©ï¼Œè®¾è®¡åˆè¡·æ˜¯ä¿ç•™ç–—æ•ˆçš„åŒæ—¶å‡å°‘æ¯’æ€§ï¼ˆç‰¹åˆ«æ˜¯è‚ºå’Œç”²çŠ¶è…ºæ¯’æ€§ï¼‰ã€‚ä½†éœ€æ³¨æ„ï¼Œåç»­ç ”ç©¶æ˜¾ç¤ºå…¶æœ‰ç‰¹å®šçš„ç¦å¿Œç—‡ï¼ˆå¦‚ç”¨äºæ°¸ä¹…æ€§æˆ¿é¢¤æˆ–å¿ƒè¡°æ‚£è€…å¯èƒ½å¢åŠ é£é™©ï¼‰ï¼Œä¸´åºŠåº”ç”¨éœ€ä¸¥æ ¼éµå¾ªæŒ‡å—ã€‚

## ğŸ“š åŒè¯­æœ¯è¯­è¡¨ (Terminology)
| è‹±æ–‡æœ¯è¯­ | ä¸­æ–‡ç¿»è¯‘ | å®šä¹‰/è§£é‡Š |
| :--- | :--- | :--- |
| Potassium Channel Blockers (Class III Antiarrhythmics) | é’¾é€šé“é˜»æ»å‰‚ï¼ˆç¬¬ä¸‰ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯ï¼‰ | é€šè¿‡é˜»æ–­é’¾ç¦»å­é€šé“ï¼Œå»¶é•¿åŠ¨ä½œç”µä½æ—¶ç¨‹å’Œæœ‰æ•ˆä¸åº”æœŸæ¥æ²»ç–—å¿ƒå¾‹å¤±å¸¸çš„è¯ç‰©ã€‚ |
| Action Potential Duration (APD) | åŠ¨ä½œç”µä½æ—¶ç¨‹ | å¿ƒè‚Œç»†èƒä»å»æåŒ–å¼€å§‹åˆ°å¤æåŒ–ç»“æŸæ‰€ç»å†çš„æ—¶é—´ã€‚ |
| Effective Refractory Period (ERP) | æœ‰æ•ˆä¸åº”æœŸ | å¿ƒè‚Œç»†èƒåœ¨ä¸€æ¬¡å…´å¥‹åï¼Œå¯¹ä»»ä½•åˆºæ¿€éƒ½ä¸èƒ½å†æ¬¡äº§ç”ŸåŠ¨ä½œç”µä½çš„æ—¶æœŸã€‚ |
| Reentry | æŠ˜è¿” | å¿ƒå¾‹å¤±å¸¸çš„ä¸€ç§å¸¸è§æœºåˆ¶ï¼ŒæŒ‡ç”µå†²åŠ¨åœ¨å¿ƒè„å†…ç¯å½¢ä¼ å¯¼ï¼ŒæŒç»­æ¿€åŠ¨å¿ƒè‚Œã€‚ |
| Amiodarone (Amio) | èƒºç¢˜é…® | ä¸€ç§å¹¿è°±ã€å¼ºæ•ˆä½†å‰¯ä½œç”¨å¤æ‚çš„ç¬¬ä¸‰ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯ï¼Œå…·æœ‰æ‰€æœ‰å››ç±»è¯ç‰©çš„ç‰¹æ€§ã€‚ |
| Dronedarone | å†³å¥ˆè¾¾éš† | èƒºç¢˜é…®çš„è¡ç”Ÿç‰©ï¼Œæ—¨åœ¨å‡å°‘å™¨å®˜æ¯’æ€§ï¼Œä¸»è¦ç”¨äºç‰¹å®šç±»å‹çš„æˆ¿é¢¤ã€‚ |
| Sotalol | ç´¢ä»–æ´›å°” | å…¼å…·Î²å—ä½“é˜»æ»ï¼ˆIIç±»ï¼‰å’Œé’¾é€šé“é˜»æ»ï¼ˆIIIç±»ï¼‰ä½œç”¨çš„æŠ—å¿ƒå¾‹å¤±å¸¸è¯ã€‚ |
| Dofetilide | å¤šéåˆ©ç‰¹ | ä¸€ç§â€œçº¯â€çš„ç¬¬ä¸‰ç±»æŠ—å¿ƒå¾‹å¤±å¸¸è¯ï¼Œä¸»è¦ç”¨äºæˆ¿é¢¤/æˆ¿æ‰‘çš„è½¬å¤å’Œçª¦å¾‹ç»´æŒã€‚ |
| Ibutilide | ä¼Šå¸ƒåˆ©ç‰¹ | é™è„‰ç”¨ç¬¬ä¸‰ç±»è¯ç‰©ï¼Œå‡ ä¹ä¸“ç”¨äºæˆ¿é¢¤/æˆ¿æ‰‘çš„å¿«é€Ÿè¯ç‰©å¤å¾‹ã€‚ |
| Torsade de Pointes (Torsade) | å°–ç«¯æ‰­è½¬å‹å®¤é€Ÿ | ä¸€ç§ä¸QTé—´æœŸå»¶é•¿ç›¸å…³çš„ç‰¹æ®Šå¤šå½¢æ€§å®¤æ€§å¿ƒåŠ¨è¿‡é€Ÿï¼Œæœ‰çŒæ­»é£é™©ã€‚ |
| QT Interval / QTc | QTé—´æœŸ / æ ¡æ­£åQTé—´æœŸ | å¿ƒç”µå›¾ä¸Šä»QRSæ³¢å¼€å§‹åˆ°Tæ³¢ç»“æŸçš„æ—¶é—´ï¼Œåæ˜ å¿ƒå®¤é™¤æå’Œå¤æçš„æ€»æ—¶é—´ã€‚QTcæ˜¯ç»å¿ƒç‡æ ¡æ­£åçš„å€¼ã€‚ |
| Pulmonary Fibrosis | è‚ºçº¤ç»´åŒ– | èƒºç¢˜é…®æœ€ä¸¥é‡çš„é•¿æœŸå‰¯ä½œç”¨ä¹‹ä¸€ï¼ŒæŒ‡è‚ºç»„ç»‡ç˜¢ç—•åŒ–ï¼Œå¯¼è‡´å‘¼å¸åŠŸèƒ½è¿›è¡Œæ€§ä¸‹é™ã€‚ |
| Pharmacologic Cardioversion | è¯ç‰©å¤å¾‹ | ä½¿ç”¨æŠ—å¿ƒå¾‹å¤±å¸¸è¯ç‰©å°†å¼‚å¸¸å¿ƒå¾‹ï¼ˆå¦‚æˆ¿é¢¤ï¼‰è½¬å¤ä¸ºæ­£å¸¸çª¦æ€§å¿ƒå¾‹ã€‚ |

## ğŸ—ºï¸ çŸ¥è¯†å›¾è°±
```mermaid
mindmap
  root(("04. æŠ—å¿ƒå¾‹å¤±å¸¸è¯ç¬¬å››è®²ï¼šé’¾é€šé“é˜»æ»å‰‚ (ç¬¬ä¸‰ç±»è¯ç‰©)"))
    ("æ ¸å¿ƒæœºåˆ¶")
      ("é˜»æ–­é’¾é€šé“")
      ("å»¶é•¿åŠ¨ä½œç”µä½æ—¶ç¨‹ (APD)")
      ("å»¶é•¿æœ‰æ•ˆä¸åº”æœŸ (ERP)")
      ("æœ‰æ•ˆç»ˆæ­¢æŠ˜è¿”æ€§å¿ƒå¾‹å¤±å¸¸")
    ("ä¸»è¦è¯ç‰© (ç¾å›½å¸¸ç”¨)")
      ("èƒºç¢˜é…® (Amiodarone)")
        ("â€œå¤šé¢æ‰‹â€ï¼šå…¼å…·I, II, III, IVç±»ä½œç”¨")
        ("å¹¿è°±é€‚åº”ç—‡ï¼šå®¤é€Ÿã€æˆ¿é¢¤/æˆ¿æ‰‘ç»´æŒçª¦å¾‹ã€æ§åˆ¶å¿ƒå®¤ç‡")
        ("ä¸¥é‡å‰¯ä½œç”¨ï¼šè‚ºçº¤ç»´åŒ–ã€ç”²çŠ¶è…ºåŠŸèƒ½å¼‚å¸¸ã€è‚æ¯’æ€§ç­‰")
        ("ç‹¬ç‰¹è¯ä»£åŠ¨åŠ›å­¦ï¼šè´Ÿè·å‰‚é‡ã€åŠè¡°æœŸæé•¿")
        ("ä¸´åºŠå®šä½ï¼šå¼ºæ•ˆä½†æ¯’æ€§å¤§ï¼Œé•¿æœŸæ²»ç–—ä¸ºäºŒ/ä¸‰çº¿")
      ("å†³å¥ˆè¾¾éš† (Dronedarone)")
        ("èƒºç¢˜é…®ç±»ä¼¼ç‰©ï¼Œæ—¨åœ¨å‡å°‘æ¯’æ€§")
        ("ç”¨äºç‰¹å®šç±»å‹æˆ¿é¢¤")
      ("ç´¢ä»–æ´›å°” (Sotalol)")
        ("å…¼å…·IIç±» (Î²é˜»æ») å’ŒIIIç±»ä½œç”¨")
      ("å¤šéåˆ©ç‰¹ (Dofetilide)")
        ("â€œçº¯â€IIIç±»è¯ç‰©")
    ("é‡è¦æ¦‚å¿µä¸é£é™©")
      ("å°–ç«¯æ‰­è½¬å‹å®¤é€Ÿ (Torsade de Pointes)")
        ("å®šä¹‰ï¼šQTå»¶é•¿å¯¼è‡´çš„å¤šå½¢æ€§å®¤é€Ÿ")
        ("å±é™©ï¼šå¯è‡´å®¤é¢¤ã€çŒæ­»")
        ("è¯±å› ï¼šè¯ç‰© (å¦‚IIIç±»è¯)ã€ç”µè§£è´¨ç´Šä¹±ã€é—ä¼ ")
        ("ç›‘æµ‹å…³é”®ï¼šQTcé—´æœŸ (è­¦æƒ• >500ms)")
        ("ä¸€çº¿æ²»ç–—ï¼šé™è„‰æ³¨å°„é•å‰‚")
      ("QTé—´æœŸå»¶é•¿")
        ("æ˜¯IIIç±»è¯ç‰©çš„é¢„æœŸè¯ç†ä½œç”¨")
        ("è¿‡åº¦å»¶é•¿åˆ™è½¬åŒ–ä¸ºé£é™©")
    ("å…¶ä»–è¯ç‰©")
      ("ä¼Šå¸ƒåˆ©ç‰¹ (Ibutilide)")
        ("é™è„‰ç»™è¯")
        ("ä¸“ç”¨äºæˆ¿é¢¤/æˆ¿æ‰‘çš„è¯ç‰©å¤å¾‹")
```
